QQ客服 官方微博 反馈留言

	Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study
	Wang, Lixin; Chen, Guofeng; Shen, Jianliang; Luo, Jianmin; Fang, Meiyun; Wei, Xudong; Li, Yinghua; Liu, Zhuogang; Zhang, Yin; Gao, Sujun
刊名	BLOOD
	2018
卷号	132
ISSN号	0006-4971
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3535604
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Wang, Lixin,Chen, Guofeng,Shen, Jianliang,et al. Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study[J]. BLOOD,2018,132.
APA	Wang, Lixin.,Chen, Guofeng.,Shen, Jianliang.,Luo, Jianmin.,Fang, Meiyun.,...&Yu, Li.(2018).Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study.BLOOD,132.
MLA	Wang, Lixin,et al."Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study".BLOOD 132(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。